Breaking Finance News

Everest Re Group Ltd (NYSE:RE) target price raised to $305.00, reported today by Barclays Capital

Everest Re Group Ltd (NYSE:RE) had its stock price target increased to $305.00 by Barclays Capital in a report issued 08/11/2017. The upped price target implies a potential upside of 0.15% based on the company's last closing price.

Previously on Friday August 11, 2017, Barclays reported on Everest Re Group Ltd (NYSE:RE) raised the target price from $299.00 to $305.00. At the time, this indicated a possible upside of 0.13%.

Just yesterday Everest Re Group Ltd (NYSE:RE) traded -1.57% lower at $265.07. The company’s 50-day moving average is $263.19 and its two hundred day average is $245.23. With the last close up 8.09% relative to the two hundred day average, compared with the S&P 500 Index which has increased 0.05% over the date range. Volume of trade was down over the average, with 218,581 shares of RE changing hands under the typical 456,833

Performance Chart

Everest Re Group Ltd (NYSE:RE)

With a market capitalization of $0, Everest Re Group Ltd has 52 week low of $183.04 and a 52 week high of $277.17 with a PE ratio of 9.09 .

In addition to Barclays Capital reporting its stock price target, a total of 8 brokers have issued a report on RE. The one year target is $195.75 with zero equity analysts rating the company a strong buy, 2 firms rating the stock a buy, nine analysts rating the company a hold, one analyst rating the company a underperform, and finally 0 brokers rating the stock a sell.

Brief Synopsis On Everest Re Group Ltd (NYSE:RE)

Everest Re Group, Ltd., through its subsidiaries, is engaged in the underwriting of reinsurance and insurance in the United States, Bermuda and international markets. The Company operates in segments: U.S. Reinsurance, International, Bermuda and Insurance segment. The Company underwrites reinsurance both through brokers and directly with ceding companies. The Company underwrites insurance principally through general agent relationships, brokers and surplus lines brokers. The Company offers treaty and facultative reinsurance, and admitted and non-admitted insurance. Its products include the range of property and casualty reinsurance, and insurance coverage's, including marine, aviation, surety, errors and omissions liability (E&O), directors' and officers' liability (D&O), medical malpractice, other specialty lines, accident and health (A&H) and workers' compensation. Its subsidiaries include Everest Reinsurance (Bermuda), Ltd. (Bermuda Re) and Everest International Reinsurance, Ltd.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.